SLN
Silence Therapeutics PLC
10.60$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +552.4% | -30.0% | -85.6% | +734.1% | +16.8% | -88.2% | +220.1% | +282.5% | +107.9% | -45.4% | -22.0% | +37.3% | -69.6% | -77.4% | -28.2% | -87.2% | – | – | -97.9% | -100.0% | – | +2,145.5% | +126.6% | +42.2% | +43.7% | +70.5% | -98.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | +38.6% | -24.4% | +14.7% | -42.3% | +0.5% | +67.2% | +57.3% | -19.9% | +22.4% | -8.8% | +22.7% | – | – | +98.2% | +47.2% | -6.0% | +14.5% | -98.2% | |
| – | – | – | +552.4% | -30.0% | -85.6% | +734.1% | +16.8% | -209.3% | – | +282.5% | -140.9% | – | – | – | – | – | – | – | – | – | – | – | – | +603.7% | +188.8% | +34.7% | +125.5% | +108.9% | -98.9% | |
| – | +85.6% | -8.0% | +80.9% | -1.5% | -17.0% | -1.4% | +22.6% | -43.7% | -2.2% | +92.0% | +52.0% | +38.6% | -24.4% | +14.8% | -42.3% | +0.5% | +67.2% | +57.3% | -19.9% | +22.4% | -8.8% | +22.7% | +36.9% | +51.5% | +52.2% | +15.4% | +24.0% | +54.2% | -0.2% | |
| – | – | – | – | – | – | – | +43.6% | +82.1% | +50.2% | +10.2% | +64.8% | -34.1% | -2.9% | +60.7% | -48.4% | -1.3% | +35.5% | -8.0% | -18.5% | +49.3% | +63.0% | +67.5% | -11.0% | +45.0% | +43.1% | +4.6% | -1.4% | +30.3% | -16.9% | |
| – | +73.6% | -2.1% | +68.0% | +4.1% | -14.3% | -0.3% | +27.3% | -56.5% | +151.7% | +41.2% | -22.1% | -32.0% | +182.1% | -44.7% | -39.2% | +640.6% | -84.7% | -8.0% | -18.5% | +49.3% | +63.0% | +67.5% | +112.2% | +63.5% | +35.2% | +11.2% | +14.6% | +46.6% | -4.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +42.7% | -18.6% | -49.7% | +209.8% | -5.1% | -37.0% | -28.5% | -67.1% | -98.6% | +0.0% | +54,300.0% | -94.3% | +48.4% | +37.0% | -79.4% | +130.8% | +133.3% | +110.0% | +131.3% | +354.1% | -99.0% | +200.0% | -26.7% | -51.5% | -50.0% | +487.5% | -27.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -330.6% | – | – | – | – | – | – | – | – | – | – | -135.8% | – | – | – | – | – | – | – | – | – | – | – | -1,355.8% | – | -98.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.